AZD8075

DRUG2 trials

Sponsors

AstraZeneca

Conditions

HealthyHealthy Volunteers

Phase 1

AZD8075 Single Ascending Dose Study

TerminatedNCT00787072

AstraZenecaHealthy Volunteers

Start: 2008-10-31End: 2009-01-31Target: 72Updated: 2010-12-02

AZD8075 Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male Volunteers

WithdrawnNCT00829127

AstraZenecaHealthy

Start: 2009-01-31End: 2009-01-31Target: 27Updated: 2011-08-25